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Risk-Adjusted Models of
30-Day Mortality Following
Coronary Intervention
How Can They Be Made More Clinically Relevant?*
Lloyd W. Klein, MD, Justin Maroney, MD
Chicago, Illinois
Risk-adjusted prediction models of percutaneous coronary
interventional (PCI) outcomes have several purposes. Fore-
most is their utility to assess programmatic and operator
quality, and are now considered the standard for this
purpose, supplanting procedural volume and unadjusted
complication rates (1). Less successful has been their
application in clinical practice to assist decision making.
This seems surprising, given the success that the Society of
Thoracic Surgeons (STS) Registry (2) and EuroSCORE (3)
have achieved in assessing the risks of coronary artery bypass
grafting (CABG).
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One critical limitation of PCI risk models is that although
highly predictive of in-hospital mortality, most are not
constructed to predict longer-term survival or other proce-
dural complications (1). In this issue of JACC: Cardiovas-
cular Interventions, Hannan et al. (4) present a highly
accurate in-hospital and 30-day mortality prediction model
derived from the New York State PCI Reporting System
2010 data (NYS-2010-score). There were 54,223 patients
who underwent PCI at 58 hospitals included in the registry,
with an overall in-hospital/30-day mortality rate of 1.03%.
A logistic model was constructed to identify the factors that
were signiﬁcantly related to mortality, and each was then
assigned an integer value reﬂecting its relative correlation
with mortality. The resulting score is a straightforward
additive calculation with results ranging from 0 to 43.
Clinical factors included in the model are similar to those
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to the contents of this paper to disclose.the model was 0.89, demonstrating quite similar discrimi-
nation to other mortality models, and the Hosmer-
Lemeshow statistic was 16.11, indicating fair calibration.
Predicted mortality ranged from 0.09% for a risk score of 0,
to a maximum risk score of 43, denoting a mortality risk of
99.94%. This risk model has several strengths: it is easy to
calculate, and the score is easily comprehended. The vari-
ables used to construct the model are objectively deﬁned.
The population cohort from whom the score is derived is
large, reﬂecting the practices of a large and varied number
of operators and institutions. Registry data collection is
compulsory rather than voluntary, and is routinely audited
for accuracy and completeness.
The NYS-2010-score presents an accurate, easy-to-use
prediction tool that would appear to be useful in clinical
decision making. So why hasn’t a quantitative approach to
pre-PCI risk assessment gained widespread utilization,
similar to the CABG scores? In part, the distribution of
low-risk versus high-risk patients undergoing PCI limits the
clinical utility of all current risk scores. Using 1% and 5%
in-hospital/30-day mortality as rough thresholds for low-risk
and high-risk patients, respectively, the user ﬁnds a prob-
lematic distribution. In the registry, 87.9% of patients had risk
scores 8, corresponding with a predicted risk of 1.31%.
Hence, the vast majority of patients receiving PCI are at low
risk, with little gradient of risk conveyed by the model.
Conversely, only 3.8% of patients had risk scores 12, cor-
responding to a predicted risk >4.79%. Moreover, nearly all
the individual risk factors contributing 5 points to the risk
score are intuitively obvious (presence of shock, ST-segment
elevation myocardial infarctiondany timing, age 86 years,
renal failure requiring dialysis, and recent non–ST-segment
elevation myocardial infarction). Perhaps most signiﬁcantly,
just 9.3% of all patients are “intermediate” risk, and these are
differentiated into only 3 levels of gradation.
The NYS-2010-score extends the mortality endpoint to
30 days from the index procedure to more accurately reﬂect
short-term mortality after PCI. Thirty-day mortality was
found to be 40% greater than in-hospital mortality, similar
to previously reported data (5). In utilizing the NYS-2010-
score for purposes of evaluating individual operator and
institutional risk-adjusted outcomes, one must consider to
what degree expanding the endpoint to include 30-day
mortality may confound procedural-related mortality with
that resulting from overall disease burden and/or inade-
quately treated comorbid conditions after discharge.Inherent Limitations of
Quantitative Mortality Models
There is little experience in developing risk scores to predict
health status or quality of life, which may be what the
majority of patients value most, particularly the elderly (6).
Klein and Maroney J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 6 , 2 0 1 3
How Can Risk Adjusted Models of Mortality After PCI Be Made More Relevant? J U N E 2 0 1 3 : 6 2 3 – 4
624By any measure, short-term survival is not the outcome that
best captures what concerns patients, nor the best gauge of
revascularization strategy (7,8), and may further emphasize
the power of risk aversion in medical decision making (9).
The value of the models is determined entirely by the
speciﬁc variables collected by the sponsoring registry.
Therefore, although highly accurate as a metric of program-
matic and operator quality in large populations, there are
intrinsic limitations when applied to particular patients. For
example, existing registries do not collect speciﬁc data con-
cerning patient frailty (10), incomplete revascularization
(7,11), patient preferences, many comorbid conditions, or
other extenuating circumstances that may be highly relevant
to the decisions being made.
Moreover, although the models accurately evaluate
procedural risk, they do not assess potential beneﬁt. Hence,
they cannot be used to appraise the risk–beneﬁt ratio, which
is the foundation of clinical judgment. For this reason, they
cannot be used to evaluate the appropriateness of the
intervention and thus cannot be the determining factor in
decision making (12).
Recent models incorporate integer-based risk scores to
quantify the risk from the PCI procedure; this simpliﬁes
their use by patients and their healthcare providers. How-
ever, few busy clinicians will carry around the point systems
for these models. Online open access to STS allow-
ing calculation has facilitated the use of this model for
CABG, and its value as a teaching tool as well as a useful
instrument for the clinician is unquestioned. Why the
National Cardiovascular Data Registry (NCDR) does not
have similar access to its algorithms (5,13) for its users on
its website is incomprehensible. NCDR also has excellent
models that predict bleeding and renal dysfunction, as well
as outcomes in speciﬁc patient subsets, that should not be
relegated to a dusty library but rather used by doctors in
everyday practice. Although less useful, there are free
mobile device programs that allow lesion-speciﬁc calcula-
tions of PCI risk.
Probably the most signiﬁcant limitation of these models,
including the NYS-2010-score, is that each is statistically
dominated by cardiogenic shock, acute MI, and poor left
ventricular function. These evident associations limit the
applicability of the models in the patients for whom an
objective assessment of risk might be particularly impactful.
One solution may be the development of separate models for
stable coronary artery disease patients. Strictly speaking, this
would not be necessary if there were adequate predictive
discrimination in the intermediate range; however, as is clear
in Hannan et al. (4), this is not typically the case because the
majority of the population selected for PCI in contemporary
practice present with an acute coronary syndrome.The challenge for future PCI risk models is to overcome
the limitations imposed by the existing structure of the
registries from which they are derived and become more
accessible for real-time clinical decision making. To
accomplish this transformation, they must be modiﬁed to
integrate factors and outcomes that will more effectively
guide physicians and patients.Reprint requests and correspondence: Dr. Lloyd W. Klein,
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